Latest Apreo Health News & Updates

See the latest news and media coverage for Apreo Health. We track all announcements, press releases, and industry mentions in real time, all in one place.

Apreo Health

Clinical-stage medical device company developing emphysema treatments

apreohealth.com

Headquarters: Menlo Park, United States
Company type: Private company
Number of employees: 34–50
Industry: Biotechnology & Medical Research

Last updated October 28

Latest news about Apreo Health

In short: Apreo Health reported BREATHE-3 treatment milestones in the U.S., U.K. and Germany.

Company announcements

October 28 Apreo Health

Apreo Health treats first BREATHE-3 study patient

The milestone involves the Apreo BREATHE Airway Scaffold for severe COPD, evaluated by Barts Health NHS Trust.

October 16 Apreo Health

Apreo Health announces Breathe-3 first case in Germany

Thoraxklinik Heidelberg performed the procedure using the Apreo BREATHE Airway Scaffold for severe emphysema patients, advancing minimally invasive bronchoscopic treatments.

September 16 Apreo Health

Apreo Health enrolls patients in BREATHE-3 trial

Evaluating the Apreo BREATHE Airway Scaffold for severe emphysema across 18 US sites.

September 8 Apreo Health

Apreo Health enrolls patients in BREATHE-3 trial

The clinical trial studies the Apreo BREATHE Airway Scaffold for severe emphysema treatment across U.S. medical centers.

Media coverage

June 21 Applied Clinical Trials

Apreo Health Launches Pivotal BREATHE-3 Trial for Severe Emphysema | Applied Clinical Trials Online

The trial’s first patient has been treated to assess the BREATHE Airway Scaffold, which was developed to enhance breathing and daily functioning in patients with...

September 3, 2025 Temple Health

Temple Lung Center Performs First U.S. BREATHE-3 Procedure for Severe Emphysema - Temple Health

The Phase-3 trial of Apreo Health’s bronchoscopic airway scaffold for severe emphysema and hyperinflation is now enrolling at the Temple Lung Center.

August 7, 2025 Medical Device Network

Apreo Health raises $130m to fund emphysema implant pivotal trial - Medical Device Network

California-based startup Apreo Health has raised $130m to further the development of its implant for treating severe emphysema.

August 7, 2025 Business Wire

Apreo Health Closes $130 Million Series B Financing to Advance Pivotal Trial and Early Commercialization of Breakthrough Airway Scaffold for Severe Emphysema

Apreo Health, a clinical-stage medical device company developing a novel treatment for severe emphysema, today announced the closing of an oversubscribed $13...

Never miss news about Apreo Health

Track Apreo Health and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.